Powered by science
Driven by passion

Farzin Farzaneh, PhD, FRCPath, FRSB, is Chief Scientific Officer of ViroCell Biologics and serves as a member of the Board of Directors. He is also Chair of Molecular Medicine at King’s College London and Trans-campus Professor of Molecular Medicine at Technical University of Dresden, Germany.

He established the Rayne Cell and Gene Therapy Suite (RCTS) for the GMP manufacture of Investigational Medicinal Products (IMP) and Advanced Therapy Medicinal Products (ATMP) at King’s in 2001. This facility has produced the largest number of viral vectors for gene therapy based clinical studies in Europe. He is also Member of the MHRA Commission on Human Medicines: Clinical Trials, Biologicals & Vaccines (CTBV) Expert Advisory Group.

Toni Trevett, FCIPD, is Chief People Officer at ViroCell Biologics. She has spent many years working and consulting in people management and has held leadership roles in large corporations in the UK, including as an HR Director within the BAA Plc group. 

Toni has worked in organizations in various industries including Talbot Underwriting Ltd., Lewis Silkin LLB, AAT, BAT Plc, Stihl, and Featurespace, among others.